CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Wednesday

CollPlant Biotechnologies (NASDAQ:CLGN) is projected to post its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect CollPlant Biotechnologies to post earnings of ($0.42) per share and revenue of $0.36 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

CollPlant Biotechnologies Stock Up 0.3 %

NASDAQ CLGN opened at $3.11 on Tuesday. CollPlant Biotechnologies has a 52 week low of $3.00 and a 52 week high of $6.75. The company has a market capitalization of $35.63 million, a P/E ratio of -2.02 and a beta of 1.07. The stock’s 50-day moving average price is $3.55 and its 200-day moving average price is $3.99.

Analyst Ratings Changes

A number of research firms have commented on CLGN. D. Boral Capital restated a “buy” rating and set a $14.00 target price on shares of CollPlant Biotechnologies in a research note on Wednesday, February 12th. HC Wainwright restated a “buy” rating and set a $11.00 target price on shares of CollPlant Biotechnologies in a research note on Friday, November 29th.

CollPlant Biotechnologies Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.